{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2021-07-27",
    "results": {
      "skip": 0,
      "limit": 2,
      "total": 196
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20200929",
          "submission_class_code": "UNKNOWN",
          "application_docs": [
            {
              "id": "65093",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/203007Orig1s000ltr.pdf",
              "date": "20201030",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "ANDA203007",
      "sponsor_name": "NATCO PHARMA LTD",
      "openfda": {
        "application_number": [
          "ANDA203007"
        ],
        "brand_name": [
          "LAPATINIB"
        ],
        "generic_name": [
          "LAPATINIB"
        ],
        "manufacturer_name": [
          "Lupin Pharmaceuticals, Inc."
        ],
        "product_ndc": [
          "68180-801"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "LAPATINIB DITOSYLATE"
        ],
        "rxcui": [
          "672149"
        ],
        "spl_id": [
          "50d0dd0c-7682-43d0-aa1b-ca26e9181aee"
        ],
        "spl_set_id": [
          "50d0dd0c-7682-43d0-aa1b-ca26e9181aee"
        ],
        "package_ndc": [
          "68180-801-36"
        ],
        "unii": [
          "G873GX646R"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "LAPATINIB DITOSYLATE",
          "active_ingredients": [
            {
              "name": "LAPATINIB DITOSYLATE",
              "strength": "EQ 250MG BASE"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription",
          "te_code": "AB"
        }
      ]
    },
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "7",
          "submission_status": "AP",
          "submission_status_date": "20200225",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5",
          "submission_status": "AP",
          "submission_status_date": "20200818",
          "review_priority": "STANDARD",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20200225",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling"
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20130729",
          "submission_class_code": "N/A",
          "submission_class_code_description": "Not Applicable",
          "application_docs": [
            {
              "id": "32080",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/201046Orig1s000ltr.pdf",
              "date": "20130731",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "4",
          "submission_status": "AP",
          "submission_status_date": "20200225",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20200225",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling"
        }
      ],
      "application_number": "ANDA201046",
      "sponsor_name": "LUPIN LTD",
      "openfda": {
        "application_number": [
          "ANDA201046"
        ],
        "brand_name": [
          "RANOLAZINE"
        ],
        "generic_name": [
          "RANOLAZINE"
        ],
        "manufacturer_name": [
          "Lupin Pharmaceuticals, Inc."
        ],
        "product_ndc": [
          "68180-354",
          "68180-355"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "RANOLAZINE"
        ],
        "rxcui": [
          "616749",
          "728231"
        ],
        "spl_id": [
          "8b6a8647-5561-49f8-a346-2f5af75a6162"
        ],
        "spl_set_id": [
          "595821d7-1fbf-49a5-9c62-d78f27af39b4"
        ],
        "package_ndc": [
          "68180-354-07",
          "68180-354-02",
          "68180-355-07",
          "68180-355-02"
        ],
        "nui": [
          "N0000175427",
          "N0000190114",
          "N0000185503",
          "N0000182137",
          "N0000187061"
        ],
        "pharm_class_epc": [
          "Anti-anginal [EPC]"
        ],
        "pharm_class_moa": [
          "Cytochrome P450 3A Inhibitors [MoA]",
          "P-Glycoprotein Inhibitors [MoA]",
          "Cytochrome P450 2D6 Inhibitors [MoA]",
          "Organic Cation Transporter 2 Inhibitors [MoA]"
        ],
        "unii": [
          "A6IEZ5M406"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "RANOLAZINE",
          "active_ingredients": [
            {
              "name": "RANOLAZINE",
              "strength": "500MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET, EXTENDED RELEASE",
          "route": "ORAL",
          "marketing_status": "Prescription",
          "te_code": "AB"
        },
        {
          "product_number": "002",
          "reference_drug": "No",
          "brand_name": "RANOLAZINE",
          "active_ingredients": [
            {
              "name": "RANOLAZINE",
              "strength": "1GM"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET, EXTENDED RELEASE",
          "route": "ORAL",
          "marketing_status": "Prescription",
          "te_code": "AB"
        }
      ]
    }
  ]
}